EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Biphasic Effects on Allergen‐Specific Type 2 Memory B Cells Over 18 Months Sublingual Immunotherapy for House Dust Mite Allergy

Lin Hsin iD, Simone Reinwald iD, Anouk von Borstel iD, Pei Mun Aui iD, Kirsten Deckert, P Mark Hogarth iD, Laurent Mascarell iD, Mark Hew iD, Robyn E O'Hehir iD, Menno C van Zelm iD

Allergy · 2026-06 · 81 (6) · 2172-2183

DOI: 10.1111/all.70342 ↗

At a glance

Journal article in Allergy, published online on 2026-04-17. Written by Lin Hsin and 9 co-authors. Institution: Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia. Major MEDLINE topics: Antigens, Dermatophagoides, B-Lymphocytes, Dust Mite Allergy, Immunologic Memory. Cited 1 times so far (Crossref); 59 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Health and Medical Research Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Type 2 memory B cells (Bmem) are the reservoir of pathogenic IgE in allergies. Allergen immunotherapy (AIT) can change the course of disease, but if it involves reprogramming of allergen‐reactive Bmem remains unknown. Here, we examine how AIT affects allergen‐specific Bmem in house dust mite (HDM) allergic patients.

Methods

HDM allergic patients were longitudinally evaluated over 18 months with or without sublingual HDM‐AIT. Visual analog scores, lung function tests, medication scores, serum IgE, and flowcytometric analysis of Der p 1 and Der p 2‐specific Type 2 Bmem were performed at t = 0, 4, 12, and 18 months.

Results

Patients on HDM‐AIT showed clinical improvement over 18 months with reduced intake of other medications and increases in specific serum IgE, IgG2, and IgG4. Allergen‐specific Bmem and the proportions of Type 2 Bmem therein became more abundant at 4 and 12 months and showed upregulation of CD29 and IgG4. At 18 months, the Type 2 Bmem proportions were reduced.

Conclusion

A biphasic Bmem response with early phenotypic changes followed by loss of the Type 2 state was observed during 18 months of AIT. As durable unresponsiveness takes 18 months of AIT, deletion of Type 2 Bmem is likely an important step in disease attenuation. Interventions that expedite this outcome may be beneficial in driving remission.

Subjects

MeSH terms (MEDLINE)

Antigens, DermatophagoidesB-LymphocytesDust Mite AllergyImmunologic MemoryMemory B CellsSublingual ImmunotherapyDermatophagoides pteronyssinusAnimalsFemaleHumansMaleAllergensArthropod ProteinsImmunoglobulin EImmunoglobulin GTreatment Outcome

Author keywords

allergen immunotherapyallergic rhinitis (AR)atopic asthmahouse dust mitetype 2 memory B cells

Substances

AllergensAntigens, DermatophagoidesArthropod ProteinsImmunoglobulin EImmunoglobulin G

Authors and institutions

  • Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
  • Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Victoria, Australia.
  • Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands.
  • Immune Therapies Group, Burnet Institute, Melbourne, Victoria, Australia.
  • Department of Clinical Pathology, the University of Melbourne, Parkville, Victoria, Australia.
  • Innovation & Science Department, Stallergenes Greer, Antony, France.

ORCID profiles: Lin Hsin, Simone Reinwald, Anouk von Borstel, Pei Mun Aui, P Mark Hogarth, Laurent Mascarell, Mark Hew, Robyn E O'Hehir, Menno C van Zelm

Funding

  • National Health and Medical Research Council

Cite

APA

Hsin, L., Reinwald, S., von Borstel, A., Aui, P. M., Deckert, K., Hogarth, P. M., Mascarell, L., Hew, M., O'Hehir, R. E., & van Zelm, M. C. (2026). Biphasic Effects on Allergen‐Specific Type 2 Memory B Cells Over 18 Months Sublingual Immunotherapy for House Dust Mite Allergy. Allergy, 81(6), 2172-2183. https://doi.org/10.1111/all.70342

Vancouver

Hsin L, Reinwald S, von Borstel A, Aui PM, Deckert K, Hogarth PM, et al. Biphasic Effects on Allergen‐Specific Type 2 Memory B Cells Over 18 Months Sublingual Immunotherapy for House Dust Mite Allergy. Allergy. 2026;81(6):2172-2183. doi:10.1111/all.70342

BibTeX
@article{Hsin2026,
  author = {Hsin, Lin and Reinwald, Simone and von Borstel, Anouk and Aui, Pei Mun and Deckert, Kirsten and Hogarth, P Mark and Mascarell, Laurent and Hew, Mark and O'Hehir, Robyn E and van Zelm, Menno C},
  title = {Biphasic Effects on Allergen‐Specific Type 2 Memory B Cells Over 18 Months Sublingual Immunotherapy for House Dust Mite Allergy},
  journal = {Allergy},
  year = {2026},
  volume = {81},
  number = {6},
  pages = {2172--2183},
  doi = {10.1111/all.70342}
}
Start for free →